An AI-Powered Marketplace Platform Helping SMBs Access Better Self-Funded Health Plans Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT," "we," "our," or "us") solely for informational purposes. The information included herein in this presentation has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers or representatives as ...

Key Takeaways HUM's growth is driven by Medicare Advantage expansion, strong retention and rising premiums.HUM is scaling CenterWell and boosting efficiency via automation and strategic acquisitions.HUM faces rising medical costs and higher debt, pressuring margins and operating leverage.Humana Inc. (HUM) benefits from a strong care delivery model centered on value-based care, increasing premiums, strategic acquisitions, an aging population in the United States and solid cash generation capacity. HUM’s shar ...

Is OSCR a good stock to buy? We came across a bullish thesis on Oscar Health, Inc. on FJ Research’s Substack. In this article, we will summarize the bulls’ thesis on OSCR. Oscar Health, Inc.'s share was trading at $12.21 as of March 23rd. Morgan Stanley Lifted GE HealthCare Target to $80 in Late October, Citing Strong Orders and Backlog Wichy/Shutterstock.com Oscar Health, Inc. operates as a healthcare technology company in the United States. OSCR is emerging as a scaled, infrastructure-like healthcare p ...

Is ELV a good stock to buy? We came across a bullish thesis on Elevance Health, Inc. on Grillo Insights’s Substack by Eric García. In this article, we will summarize the bulls’ thesis on ELV. Elevance Health, Inc.'s share was trading at $289.24 as of March 23rd. ELV’s trailing and forward P/E were 11.56 and 11.39 respectively according to Yahoo Finance. easiest LPN to RN bridge programs michaeljung/Shutterstock.com Elevance Health, Inc., together with its subsidiaries, operates as a health benefits compa ...

The Cigna Group Foundation Supports More Than 8,000 Veterans Through Community-Led Housing Stability Programs Accessibility StatementSkip Navigation BLOOMFIELD, Conn., March 24, 2026 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today released its 2025 Improving Veteran Mental Health Impact Report, highlighting the collective progress that its 22 nonprofit partners have made in supporting 8,000 veterans by expanding access to stable housing and providing in ...

Fourth Quarter and Full Year 2025 Results Teleconference Prepared Remarks January 27, 2026 Moderator: Good morning, and welcome to the UnitedHealth Group Fourth Quarter and Full Year 2025 Earnings Conference Call. A question-and-answer session will follow UnitedHealth Group's prepared remarks. As a reminder, this call is being recorded. Here is some important introductory information. This call contains "forward- looking" statements under U.S. federal securities laws. These statements are subject to risks a ...

Elevance Health Inc. (NYSE:ELV) is one of the 15 Best Stocks to Buy According to Billionaire Seth Klarman. Even though Baupost Group has trimmed a stake in Elevance Health Inc. (NYSE:ELV) by 4% during the fourth quarter of 2025, compared to filings for the previous quarter, the holding still represents the fourth-largest position of the fund in the 13F portfolio. It comprises more than 1.2 million shares. Baupost first bought shares in the company at the beginning of 2025. Back then, the stake consisted o ...

KEY TAKEAWAYS ACA Marketplace premiums doubled in 2026, driven by rising health care costs and the end of pandemic-era subsidies. As a result, more enrollees are downgrading to lower-tier health plans or leaving the ACA Marketplace entirely. Meanwhile, some states that offered additional subsidies in 2026 saw increases in enrollment for higher-tier plans. Health insurance costs under the Affordable Care Act spiked this year, and to afford their monthly premiums, more enrollees are choosing cheap ...

Core Viewpoint - Long-term investing in struggling stocks can yield significant benefits as companies recover and grow, allowing investors to buy at reasonable prices [1][2]. Group 1: Pfizer - Pfizer's revenue peaked at $100 billion due to coronavirus product sales but has since declined as demand waned and patents expired [4]. - The current trading price of Pfizer is $27.00, with a market cap of $153 billion and a forward earnings multiple of 9x, indicating it is a bargain for long-term investors [5][6][7]. - Pfizer is pursuing growth through acquisitions, including Seagen for oncology drugs and Metsera for a late-stage obesity drug candidate [6]. Group 2: UnitedHealth Group - UnitedHealth Group has faced challenges due to underestimated healthcare costs and service usage, impacting growth [8]. - The current trading price of UnitedHealth is $275.59, with a market cap of $250 billion and a forward earnings multiple of 15x, presenting a strong buying opportunity [9][11]. - The company is implementing strategies such as cutting certain plans, utilizing AI for efficiency, and adjusting prices to recover and grow [10].

K N O W L E D GE B RI E F Health, Nutrition and Population (HNP) PLAN NACER AT 20: LEGACY, LESSONS, AND THE ROAD AHEAD Vanina Camporeale Cecilia Zanetta KEY MESSAGES Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized 0 With continued support from the World Bank, the Plan Nacer model became the cornerstone of Argentina's broader efforts to build a universal public health insurance system - ensuring that all individuals, regardless of geographic ...